Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ENB | EPD |
|---|---|---|
| Price | $47.47 | $37.50 |
| Change today | ▼ 0.80% | ▼ 0.20% |
| Market cap | $105.79B | $80.97B |
| Return, 3 months | -11.8% | +5.4% |
| Return, year to date | +7.5% | +22.4% |
| Return, 1 year | +6.4% | +25.9% |
| P/E (TTM) | 25.7 | 13.0 |
| P/B | 2.5 | 2.7 |
| P/E percentile vs own 5y | 75th | 90th |
| Dividend yield | 5.68% | 5.84% |
| Revenue growth (YoY, latest qtr) | +97.1% | +60.8% |
| Net profit growth (YoY) | -32.4% | +27.6% |
| Gross margin | 25.7% | 13.2% |
| Operating margin | 13.6% | 12.8% |
| Net margin | 6.8% | 10.7% |
| Return on equity | 9.7% | 21.0% |
| Analyst target vs. price | +21.4% | +11.7% |
| Analyst buy share | 57% | 40% |
| RSI (14) | 38 | 44 |
| 30-day volatility | 19.0% | 16.0% |
| Max drawdown, 1 year | -15.4% | -9.3% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.